الوصف

Gastrointestinal symptom severity scores for children with cerebral palsy and chronic constipation across the four treatment arms. The data compare probiotic, prebiotic, synbiotic, and placebo groups over the study period.

Figure 3

Chart

Source Paper

Lactobacillus reuteri DSM 17938 and Agave Inulin in Children with Cerebral Palsy and Chronic Constipation: A Double-Blind Randomized Placebo Controlled …

Nutrients (2020)

PMID: 32998471

DOI: 10.3390/nu12102971

Cite This Figure

![Figure 3: Gastrointestinal symptom severity scores for children with cerebral palsy and chronic constipation across the four treatment arms. The data compare probiotic, prebiotic, synbiotic, and placebo groups over the study period.]()

> Source: Andrea A García Contreras et al. "Lactobacillus reuteri DSM 17938 and Agave Inulin in Children with Cerebral Palsy." *Nutrients*, 2020. PMID: [32998471](https://pubmed.ncbi.nlm.nih.gov/32998471/)

<figure>
  <img src="" alt="Gastrointestinal symptom severity scores for children with cerebral palsy and chronic constipation across the four treatment arms. The data compare probiotic, prebiotic, synbiotic, and placebo groups over the study period." />
  <figcaption>Figure 3. Gastrointestinal symptom severity scores for children with cerebral palsy and chronic constipation across the four treatment arms. The data compare probiotic, prebiotic, synbiotic, and placebo groups over the study period.<br>  Source: Andrea A García Contreras et al. "Lactobacillus reuteri DSM 17938 and Agave Inulin in Children with Cerebral Palsy." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32998471/">32998471</a></figcaption>
</figure>

أدلة ذات صلة

Inulin لـ Chronic Constipation

التقييم B · 6 دراسات